Penn State Health taking part in global clinical trial of antiviral drug for covid-19
Penn State Health Milton S. Hershey Medical Center has started enrolling participants in an international clinical trial evaluating an investigational antiviral drug, remdesivir, for treatment of covid-19. Remdesivir, developed by Gilead Sciences Inc., was previously tested in humans with Ebola and has shown some therapeutic benefit against SARS and MERS...